Blog

Recon: AbbVie, Voyager Partner on Gene Therapy for Alzheimer’s; Aimmune’s Peanut Allergy Drug Meets Goals in … – Regulatory Focus


Regulatory Focus

Recon: AbbVie, Voyager Partner on Gene Therapy for Alzheimer's; Aimmune's Peanut Allergy Drug Meets Goals in …
Regulatory Focus
Recon: AbbVie, Voyager Partner on Gene Therapy for Alzheimer's; Aimmune's Peanut Allergy Drug Meets Goals in Phase III. Posted 20 February 2018 | By Michael Mezher. Recon: AbbVie, Voyager Partner on Gene Therapy for Alzheimer's; Aimmune's Peanut

2018-02-20 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.